Holen Sie sich die Stockscreener-App
61.76
2.46%
1.485
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
6.91%
674.14
|
630.58 | 621.99 | 609.29 | 578.66 |
| Research and Development |
145.92%
97.85
|
39.79 | - | - | - |
| Costs And Expenses |
701.06%
541.02
|
67.54 | 233.61 | 182.13 | 368.87 |
| Operating Income/Loss |
76.36%
133.12
|
563.04 | 388.38 | 427.16 | 209.80 |
| Nonoperating Income/Loss |
45.52%
-51.63
|
-94.78 | -32.47 | 17.05 | -119.16 |
| Income/Loss From Equity Method Investments |
81.26%
4.077
|
21.76 | 4.005 | 15.95 | 2.693 |
| Income/Loss From Continuing Operations Before Tax |
82.60%
81.49
|
468.26 | 355.91 | 444.21 | 90.64 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
Net Income/Loss
|
82.60%
81.49
|
468.26 | 355.91 | 444.21 | 90.64 |
| Attributable To Noncontrolling Interest |
63.36%
63.60
|
173.57 | 141.71 | 155.99 | 60.46 |
| Basic Average Shares |
1.89%
445.06
|
436.79 | -0.48 | 431.89 | 423.51 |
| Diluted Average Shares |
0.01%
556.90
|
556.84 | -2.299 | 559.61 | 562.30 |
| Basic Earnings Per Share |
94.03%
0.04
|
0.67 | 0.50 | 0.67 | 0.07 |
| Diluted Earnings Per Share |
94.03%
0.04
|
0.67 | 0.50 | 0.67 | 0.07 |
| Common Stock Dividends |
0.00%
0.235
|
0.235 | 0.22 | 0.22 | 0.22 |
1.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):